Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02324738Phase 4Completed
A Phase 4 trial of mefloquine, dihydroartemisinin, piperaquine in malaria, sponsored by University of Oxford. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02324738.